MINNEAPOLIS - (Mealey's) The third Levaquin multidistrict litigation tendon rupture trial ended Jan. 26 with a defense verdict, defendant Johnson & Johnson's third compared to one plaintiff victory ( Clifford Straka v. Johnson & Johnson... Read More
ATLANTIC CITY, N.J. - (Mealey's) The first trial in New Jersey's Levaquin mass tort litigation ended Oct. 14 with a defense verdict for Johnson & Johnson and subsidiary Ortho-McNeil-Janssen Pharmaceuticals Inc. ( Paul Gaffney v. Johnson &... Read More
AUSTIN, Texas -- Johnson & Johnson subsidiary Janssen LLP said Jan. 19 that it has agreed to pay $158 million to settle claims by Texas that it defrauded the Medicaid program through its off-label promotion of the atypical antipsychotic drug Risperdal... Read More
NEW BRUNSWICK, N.J. - (Mealey's) A Risperdal personal injury trial ended Feb. 16 in a defense verdict for Johnson & Johnson subsidiary Janssen Pharmaceuticals Inc. after a New Jersey state court jury found that Janssen failed to warn about the... Read More
ATLANTIC CITY, N.J. - (Mealey's) A New Jersey court on Feb. 26 is hearing evidence for a punitive damages verdict in the state's first pelvic mesh bellwether trial, a day after returning a $3.35 million compensatory verdict for a woman who claims... Read More
LOS ANGELES - (Mealey's) A California state court jury on Oct. 3 awarded $48.1 million to a 22-year-old man who says Johnson & Johnson and subsidiary McNeil Consumer Healthcare failed to warn him that the nonprescription pain and fever remedy... Read More
NEW BRUNSWICK, N.J. - (Mealey's) Johnson & Johnson (J&J) expects to incur a special charge against earnings of about $600 million in the second quarter for the potential settlement of civil litigation related to Risperdal, Invega, Natrecor... Read More
LITTLE ROCK, Ark. - (Mealey's) An Arkansas state court judge on April 11 assessed a $1.1 billion penalty against the Ortho-McNeil-Janssen Pharmaceuticals Inc. subsidiary of Johnson & Johnson for thousands of violations of state trade practice... Read More
BROCKTON, Mass. - (Mealey's) A Massachusetts state court jury on Feb. 13 awarded $63 million to a family whose young daughter was severely injured by a reaction to Children's Motrin ( Lisa Reckis, et al. v. Johnson & Johnson, et al. , No.... Read More
SAN FRANCISCO -- The Scios Inc. subsidiary of Johnson & Johnson has agreed to plead guilty to a misdemeanor charge related to the off-label marketing of its Natrecor heart drug, to pay an $85 million fine and to serve three years' organizational... Read More